59) Magnetic resonance in isolated noncompaction of the ventricular myocardium
Fazio G, Novo G, D’angelo L, Visconti C, Sutera L, Grassedonio E, Galia M, Ferrara F, Midiri M, Novo S
Int J Cardiol. 2008 Dec 24. [Epub ahead of print] (IF 3,127)

71) Atherosclerosis, inflammation and Chlamidia Pneumoniae
G Fazio, M Giovino, A Gullotti, D Bacarella, G Novo, S Novo
World J Cardiol 2009; 1, 31-41

76) Atherosclerosis, inflammation and Chlamydia pneumoniae.
Fazio G, Giovino M, Gullotti A, Bacarella D, Novo G, Novo S.
World J Cardiol. 2009 Dec 31

91) Obesity: a new pathology to pay attention to in young people.
Fazio G, Vernuccio D, Di Gesaro G, Bacarella D, D’Angelo L, Novo G, Novo S.
Curr Pharm Des. 2010;16(4):463-7. (IF 4,399)

92) Asymptomatic carotid lesions add to cardiovascular risk prediction.
Novo S, Visconti CL, Amoroso GR, Corrado E, Fazio G, Muratori I, Tantillo R, Lunetta M, Dʼangelo L, Novo G.
Eur J Cardiovasc Prev Rehabil. 2010 Mar 25. [Epub ahead of print] (IF 2,361)

102) Protrhombotic Effects of Contraceptives.
Fazio G, Ferrara F, Barbaro G, Alessandro G, Ferrro G, Novo G, Novo S.
Curr Pharm Des. 2010 Sep 22 (IF 4,399)

103) Antithrombotic Therapy in Cardiovascular and Haematological Diseases: New Perspectives.
Siragusa S, Fazio G, Barbaro G.
Curr Pharm Des. 2010 Sep 22 (IF 4,399)

105) Atherosclerosis, degenerative aortic stenosis and statins.
Novo G, Fazio G, Visconti C, Carità P, Maira E, Fattouch K, Novo S.
Curr Drug Targets. 2011 Jan;12(1):115-21 (IF 3,920)

106) Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
Novo S, Fazio G, Raccuglia E, Mignano A, Novo G.
Pharmaceuticals (Basel). 2011 Sep 30;4(10):1293-1294.

107) Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction.
Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Marino Gammazza A, Corrao S, Zummo G, De Macario EC, Macario AJ,
Assennato P, Novo S, Li Volti G.
Transl Res. 2011 May;157(5):285-92. (IF 1,222)

108) Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations.
Petta S, Torres D, Fazio G, Cammà C, Cabibi D, Di Marco V, Licata A, Marchesini G, Mazzola A, Parrinello G, Novo S, Licata G, Craxì A.
Hepatology. 2012 May;55(5):1317-23. (IF 11,261)